Condition: Alzheimer Disease · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 1227 | Chandler, Arizona, United States | Completed |
| Gilbert Neurology Partners - PLLC - Avacare | Gilbert, Arizona, United States | Recruiting |
| Banner Alzheimer's Institute | Phoenix, Arizona, United States | Recruiting |
| Local Institution - 1220 | Scottsdale, Arizona, United States | Completed |
| Advanced Research Center, Inc. | Anaheim, California, United States | Recruiting |
| Inland Psychiatric Medical Group (IPMG)-Chino | Chino, California, United States | Recruiting |
| Local Institution - 1230 | Long Beach, California, United States | Completed |
| USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC) | Los Angeles, California, United States | Recruiting |
| Local Institution - 1219 | Los Angeles, California, United States | Withdrawn |
| Local Institution - 1001 | Orange, California, United States | Completed |
| Local Institution - 1228 | Orange, California, United States | Completed |
| Local Institution - 1043 | Pasadena, California, United States | Active Not Recruiting |
+ 280 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06585787